Conversely, a reduction in TFF3 (or an increase in IGFBP5) following tamoxifen treatment in vivo and the protein levels in primary tumors correlated with a reduction in tumor volume in the 28 patients treated with tamoxifen for three months. Here, TFF3 is linked to neoplasm.